Zobrazeno 1 - 10
of 3 954
pro vyhledávání: '"her2/neu"'
Autor:
A. V. Avgustinovich, S. G. Afanasyev, L. V. Spirina, E. V. Kaygorodova, R. V. Ermolenko, E. N. Samtsov, I. G. Frolova, O. V. Cheremisina
Publikováno v:
Сибирский онкологический журнал, Vol 23, Iss 1, Pp 170-177 (2024)
Background. Overexpression of Her2neu occurs in 15–20% of patients with gastric cancer and correlates with an unfavorable prognosis. Case report. We report a case of pathological complete regression of resectable gastric cancer with Her2/neu overex
Externí odkaz:
https://doaj.org/article/95ef8d2d9eef47ee99e031846ff9b874
Autor:
Vladimir I. Evdokimov, Anatoly A. Bloshchinenko, Alexander E. Abolmasov, Alexey A. Vilensky, Michail S. Laskov
Publikováno v:
Современная онкология, Vol 25, Iss 3, Pp 336-341 (2023)
Aim. To evaluate the effectiveness of trastuzumab deruxtecan in real-world practice in the Russian Federation. Materials and methods. We performed a retrospective analysis of clinical case series related to the use of trastuzumab deruxtecan (N=15)
Externí odkaz:
https://doaj.org/article/02e2f51c5f464211a7ce2b5365c62c79
Autor:
Semir Vranic, Zoran Gatalica
Publikováno v:
Biomolecules & Biomedicine (2024)
Oncologic treatment has recently undergone substantial therapeutic paradigm shifts, from classical tumor-specific and biomarker-agnostic approaches to more molecular, biomarker-specific, and tumor-agnostic. Tumor-type (histology) agnostic drugs work
Externí odkaz:
https://doaj.org/article/e3f3a473c5bb43eaa8f371c5848cfc3e
Autor:
Snježana Mikuličić, Merha Shamun, Annika Massenberg, Anna-Lena Franke, Kirsten Freitag, Tatjana Döring, Johannes Strunk, Stefan Tenzer, Thorsten Lang, Luise Florin
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/e54739e572c841048916675341530fda
Autor:
Snježana Mikuličić, Merha Shamun, Annika Massenberg, Anna-Lena Franke, Kirsten Freitag, Tatjana Döring, Johannes Strunk, Stefan Tenzer, Thorsten Lang, Luise Florin
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Human papillomaviruses (HPVs) are a major cause of cancer. While surgical intervention remains effective for a majority of HPV-caused cancers, the urgent need for medical treatments targeting HPV-infected cells persists. The pivotal early genes E6 an
Externí odkaz:
https://doaj.org/article/93f9fa950f2f45d383c209bb584cf5fc
Autor:
Pramod Kumar Reddy M, Rasheed Fatima, Shilpa Karamchedu, Manisha Goud Punjala, Vishali Patale, Florence N K, Suresh K
Publikováno v:
Journal of Research in Applied and Basic Medical Sciences, Vol 9, Iss 3, Pp 183-192 (2023)
Background & Aims: This study aimed to determine the significance of immunohistochemistry (IHC) and its correlation using HER-2/NEU and cytokeratins in a histopathologic study of GI neoplasms. Materials & Methods: This retrospective- prospective stud
Externí odkaz:
https://doaj.org/article/c82feaee68364d78bbef16c8b100acef
Autor:
Nguyen Thi Giang An
Publikováno v:
Tạp chí Khoa học, Vol 52, Iss 2A, Pp 68-79 (2023)
Breast cancer, a prevalent form of cancer in women, presents various categories that pose challenges in defining specific treatment approaches. Immunohistochemistry, a combination of immunology and histology, has made significant advancements in iden
Externí odkaz:
https://doaj.org/article/25fa21d9560e4dc891518f5efb82cf52
Autor:
Fatima Rasheed, Shilpa Karamchedu, Venkata Hari Charan Bagadi, Tabassum Misbah, Manisha Goud Punjala, Florence Nightingale, Karamchedu Suresh
Publikováno v:
Journal of Clinical and Basic Research, Vol 7, Iss 2, Pp 5-7 (2023)
Background: HER2/neu is associated with increased tumor grade, and Ki-67 is related to tumor recurrence and stage progression. This study aims to evaluate the clinical profile in patients with urothelial neoplasms and correlate the expression of HER2
Externí odkaz:
https://doaj.org/article/1732a4a556bd4f5182a973805854964b
Publikováno v:
European Journal of Breast Health, Vol 19, Iss 2, Pp 128-133 (2023)
Objective:The aim was to assess the prognostic variables in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer patients receiving lapatinib plus capecitabine.Materials and Methods:Retrospective data on HER2-positive met
Externí odkaz:
https://doaj.org/article/82be6058db504093bd5493194317ce8d
Autor:
Katherine Englander, Neha Chintapally, Julia Gallagher, Kelly Elleson, Weihong Sun, Junmin Whiting, Christine Laronga, Marie Catherine Lee
Publikováno v:
Current Oncology, Vol 30, Iss 3, Pp 2825-2833 (2023)
Axillary lymph node metastases are a key prognostic factor in breast cancer treatment. Our aim was to evaluate how tumor size, tumor location, and imaging results correlate to axillary lymph node diseases for patients with stage I-III HER2/neu+ breas
Externí odkaz:
https://doaj.org/article/41293a36524b4e83b76fe1bffccfa789